Diabetes Enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients

American Journal of Medicine

Volumn 123, Issue 10, 2010, Pages

  Kawamura, Yusuke ^a   Arase, Yasuji ^a   Ikeda, Kenji ^a   Hirakawa, Miharu ^a   Hosaka, Tetsuya ^a   Kobayashi, Masahiro ^a   Saitoh, Satoshi ^a   Yatsuji, Hiromi ^a   Sezaki, Hitomi ^a   Akuta, Norio ^a   Suzuki, Fumitaka ^a   Suzuki, Yoshiyuki ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Diabetes; Hepatocellular carcinoma; Interferon; Sustained virologic response

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; CARCINOMA, HEPATOCELLULAR; COMPLICATION; KAPLAN MEIER METHOD; LIVER; LIVER NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DIABETES COMPLICATIONS; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; KAPLAN-MEIERS ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RIBAVIRIN; RISK FACTORS; TIME FACTORS; YOUNG ADULT; KAPLAN-MEIER ESTIMATE;

EID: 77957774891     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.05.013     Document Type: Article

References (26)

1. J. Bruix, J.M. Barrera, and X. Calvet Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Lancet 2 1989 1004 1006
2. M. Colombo, G. Kuo, and Q.L. Choo Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma Lancet 2 1989 1006 1008
3. F. Hasan, L.J. Jeffers, and M. De Medina Hepatitis C-associated hepatocellular carcinoma Hepatology 12 1990 589 591
4. M.C. Kew, M. Houghton, Q.L. Choo, and G. Kuo Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma Lancet 335 1990 873 874 (Pubitemid 20136778)
5. S. Ohkoshi, H. Kojima, and H. Tawaraya Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma Jpn J Cancer Res 81 1990 550 553 (Pubitemid 20236565)
6. I. Saito, T. Miyamura, and A. Ohbayashi Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proc Natl Acad Sci U S A 87 1990 6547 6549
7. K. Kiyosawa, and S. Furuta Review of hepatitis C in Japan J Gastroenterol Hepatol 6 1991 383 391 Review
8. M.J. Alter, H.S. Margolis, and K. Krawczynski The natural history of community-acquired hepatitis C in the United States The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team N Engl J Med 327 1992 1899 1905
9. H. Tsukuma, T. Hiyama, and S. Tanaka Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801 (Pubitemid 23174709)
10. K. Ikeda, S. Saitoh, and I. Koida A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 1993 47 53
11. L.F. Hourigan, G.A. Macdonald, and D. Purdie Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1999 1215 1219
12. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
13. A.L. Mason, J.Y. Lau, and N. Hoang Association of diabetes mellitus and chronic hepatitis C virus infection Hepatology 29 1999 328 333
14. K.Q. Hu, N.L. Kyulo, and E. Esrailian Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States J Hepatol 40 2004 147 154
15. I.J. Hickman, E.E. Powell, and J.B. Prins In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy J Hepatol 39 2003 1042 1048
16. Y. Arase, F. Suzuki, and Y. Suzuki Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C Hepatology 49 2009 739 744
17. V.J. Desmet, M. Gerber, and J.H. Hoofnagle Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520 Review
18. S. Genuth, K.G. Alberti, and P. Bennett Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus Diabetes Care 26 2003 3160 3167
19. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
20. M. Romero-Gmez, M. Del Mar Viloria, and R.J. Andrade Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 128 2005 636 641
21. L.I. Backus, D.B. Boothroyd, B.R. Phillips, and L.A. Mole Predictors of response of US veterans to treatment for the hepatitis C virus Hepatology 46 2007 37 47
22. J.A. Davila, R.O. Morgan, and Y. Shaib Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study Gut 54 2005 533 539
23. M. Inoue, M. Iwasaki, and T. Otani Diabetes mellitus and the risk of cancer: RESULTS: from a large-scale population-based cohort study in Japan Arch Intern Med 166 2006 1871 1877
24. K. Moriya, H. Yotsuyanagi, and Y. Shintani Hepatitis C virus core protein induces hepatic steatosis in transgenic mice J Gen Virol 78 1997 1527 1531
25. K. Moriya, H. Fujie, and Y. Shintani The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 1998 1065 1067
26. Y. Shintani, H. Fujie, and H. Miyoshi Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance Gastroenterology 126 2004 840 848